Hassett: White House may review AI models ‘like an FDA drug’
Summary
The White House is thinking about making a rule that would require artificial intelligence (AI) systems to be tested and reviewed in a way similar to how the Food and Drug Administration (FDA) checks new drugs. This idea was shared by Kevin Hassett, the director of the National Economic Council, as the Trump administration deals with a new advanced AI system called Mythos.Key Facts
- The White House may issue an executive order to regulate AI models.
- The proposed process would be similar to the FDA’s drug approval system.
- Kevin Hassett, National Economic Council Director, announced this consideration.
- The Trump administration is addressing challenges posed by an advanced AI system named Mythos.
- The goal is to carefully review AI technologies before they are widely used.
- This approach aims to ensure AI is safe and reliable for the public.
- The idea reflects concern about AI’s growing impact and risks.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.